Sun Pharma weighs multiple funding options for $12 billion Organon deal | Company News
By Saikat Das  Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the matter.  The Indian drugmaker is considering seeking consent from Organon bondholders to swap their holdings…